Three vets told a House of Lords inquiry on Wednesday that flea treatments for pets should be banned from general sale. Dr Elizabeth Mullineaux said the British Veterinary Association’s surveys showed 80% of its 20,000 members backed that step, along with an end to blanket preventative treatment.
The panel also pressed for a ban on spot-on products containing fipronil and imidacloprid unless they are sold by vets. Environmental scientists have flagged those chemicals in most spot-on flea treatments as toxic to wildlife, and the Department for the Environment, Farming and Rural Affairs is already considering a ban on general sale after launching a call for evidence last month.
House of Lords inquiry
The evidence went to the Lords' environment select committee, which heard from Dr Mullineaux, Dr Martin Whitehead and Dr Rose Perkins. Mullineaux said, "We're using these products really routinely and I think if you ask most vets what they do with their own pets, we don't treat our own pets in the way some practices are selling these products". She also said more than 70% of surveyed members agreed blanket preventative treatment should stop.
Whitehead, senior veterinary surgeon at Chipping Norton Veterinary Hospital, set out the panel's sharper view of routine treatment. "Almost all the parasiticides that are preventatively applied to pets are unnecessary," he said.
Dr Rose Perkins
Perkins, a practicing vet and visiting Fellow at the Grantham Institute, described an alternative approach she said was cheaper and effective. "It's more in line with how we use antibiotics, it's much cheaper, you save a lot of money, and isoxazolines are incredibly effective," she said.
She added that government-funded research showed pollution still happens when owners apply spot-on treatments correctly. "Pollution is occurring through correct use," Perkins said. "There's actually no evidence that incorrect application or incorrect disposal of the product is a source of pollution."
Sale limits and veterinary advice
That evidence puts pressure on routine advice that pet owners across the UK have received to treat cats and dogs every month as a preventative measure. The industry body representing flea treatment companies defended preventive flea treatments as important for animal health, leaving the committee with two opposing positions: wider access for routine use, or tighter controls and vet-only supply.
For pet owners, the practical issue is simple. If Defra follows through on a general-sale ban, the products most commonly bought over the counter could move into vet-controlled supply, and the case for year-round preventative use would face closer scrutiny from the committee and from ministers reviewing the evidence.
